Aastrom Biosciences Expands Bone Graft Clinical Trial

Released on = January 10, 2005, 12:30 pm

Press Release Author = TheNewsWire.com

Industry = Financial

Press Release Summary = American Pharmaceutical Partners, Inc. (Nasdaq: APPX - News) and American Bioscience, Inc. (ABI) announced that the U.S. Food and Drug Administration (FDA) ...

Press Release Body = (EMAILWIRE.COM, January 10, 2005) Lake Harmony, Pa. -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced that it has expanded the U.S. Phase I/II clinical trial of its adult stem cell-based Tissue Repair Cells (TRCs) in the treatment of severe long bone non-union fractures to include the Department of Orthopedic Surgery at William Beaumont Hospital (Beaumont), located in Royal Oak, MI.

More Recent Hot News:

American Pharmaceutical Partners, Inc. (Nasdaq: APPX - News) and American Bioscience, Inc. (ABI) announced that the U.S. Food and Drug Administration (FDA) has approved ABRAXANE(TM) for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in metastatic breast cancer.

Public Company Management Corporation (OTC BB:PUBC.OB - News) announced that its subsidiary, Go Public Today, has signed a contract with Sputnik, Inc. to provide SB-2 securities registration services and aims to obtain an OTC BB listing for the common stock of Sputnik, Inc. in exchange for a combination of cash fees and a block of shares of Sputnik, Inc. common stock.

Ocean Bio-Chem, Inc. (Nasdaq: OBCI - News) announced that its Board of Directors approved a plan for the Company to purchase shares of the Company's Common Stock on the open market at or below its book value.

Orbit Drop (Pink Sheets:OBDP - News), the easy alternative to the traditional way of using eBay, is assisting the American Red Cross to provide trauma counseling for the rescuers with the Tsunami relief efforts. Orbit Drop's Dallas location will raise needed funding through an online auction beginning Friday, Jan. 7, 2005.

Web Site = http://www.TheNewsWire.com

Contact Details = Source: www.TheNewsWire.com
Contact: C.P. Barry
1.888.478.7669 / 570.443.0539

This press release was issued through GroupWeb EmailWire.Com. For more information,
go to http://www.emailwire.com